Product image of Linezolid Olikla (Linezolid) supplied by GNH India

Linezolid Olikla

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Olikla (Linezolid)

Linezolid, the active ingredient in Linezolid Olikla, is an oxazolidinone presented as an oral tablet for oral use. It treats infections caused by Gram‑positive bacteria, including skin and soft‑tissue infections and community‑acquired or nosocomial pneumonia.

GNH India supplies Linezolid Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Olikla S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid Olikla is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

  • Skin and soft tissue infections: effective against methicillin‑resistant Staphylococcus aureus and other susceptible organisms.
  • Community‑acquired and nosocomial pneumonia: treats pneumonia caused by susceptible Gram‑positive pathogens.
  • Complicated infections caused by Gram‑positive bacteria: used for bacteremia, endocarditis and other serious infections when other agents are unsuitable.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible Gram‑positive organisms and bactericidal at higher concentrations, providing coverage against resistant strains such as MRSA and VRE.

Side Effects

Adverse reactions may occur with linezolid therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Insomnia: difficulty sleeping.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: nerve pain or sensory changes.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Severe anemia: marked reduction in red blood cells.
  • Elevated liver enzymes: potential hepatic injury.
  • Allergic reactions: including rash, angioedema or anaphylaxis.

Precautions & Warnings

Use of linezolid requires careful clinical monitoring.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Myelosuppression: perform periodic complete blood counts.
  • Hypersensitivity: discontinue if allergic reaction occurs.
  • Store at ambient temperature: keep below 25°C, retain in original packaging and protect from moisture.

Avoid Interactions

Linezolid can interact with several drug classes.

Major Interactions (Avoid)

  • MAO inhibitors: risk of hypertensive crisis and serotonin syndrome.
  • SSRIs, SNRIs, or other serotonergic drugs: may precipitate serotonin syndrome.
  • Rifampin: induces metabolism, reducing linezolid plasma levels.
  • Warfarin: may increase anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely)

  • NSAIDs: additive effect on bleeding risk.
  • Diuretics: potential for hypotensive episodes.
  • Phenytoin: may alter linezolid concentrations, requiring monitoring.

Frequently Asked Questions

Linezolid Olikla is an oral oxazolidinone antibiotic indicated for the treatment of skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and other serious infections caused by susceptible Gram‑positive bacteria such as MRSA and VRE.

Linezolid acts by binding to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex needed for protein synthesis. This inhibition stops bacterial growth and can be bacteriostatic or bactericidal depending on the organism and drug concentration.

The specific dose and duration of Linezolid Olikla are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local antimicrobial guidelines.

The safety of linezolid during pregnancy and lactation has not been fully established. Prescribers should weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral bioavailability comparable to intravenous administration, making it convenient for outpatient therapy. Unlike beta‑lactams, it remains active against many resistant Gram‑positive organisms, including MRSA and VRE, but it lacks activity against Gram‑negative bacteria.

Store Linezolid Olikla at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed.

Linezolid Olikla is taken orally, usually as a tablet, with or without food. Patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken on an empty stomach.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic drugs, severe anemia, and rare allergic reactions such as anaphylaxis. Regular monitoring of blood counts and clinical status is recommended.

Linezolid Olikla should be avoided in patients with known hypersensitivity to linezolid or any component of the formulation, and in those taking monoamine oxidase inhibitors. Caution is advised for individuals with existing myelosuppression, severe hepatic impairment, or uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT